Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil Dosing for Tracheal Intubation (RemiTrach)
NCT03744949Completed
- Start
- Mar 2018
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of remifentanil (4 arms). Primary endpoint: ED95 of remifentanil bolus. Started Mar 2018; status: completed.
02
Drugs
remifentanil
Beyond the preview
Go deeper on NCT03744949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03744949.